May G-CSF after large anterior acute STEMI influence LV systolic and diastolic function? Results of Stem Cells Mobilization in Acute Myocardial Infarction (STEM-AMI) trial

被引：0
|
作者：
Gentile, F. [1 ]
Dadone, V. [1 ]
Lenatti, L. [2 ]
Malafronte, C. [2 ]
Pompilio, G. [3 ]
Squadroni, L. [4 ]
Di Gennaro, F. [5 ]
Maggiolini, S. [6 ]
Colombo, G. [3 ]
Achilli, F. [2 ]
机构：
[1] Bassini Hosp, Dept Cardiol, Cinisello Balsamo, Italy
[2] Alessandro Manzoni Hosp, Lecce, Italy
[3] Cardiol Ctr Monzino IRCCS, Milan, Italy
[4] San Carlo Borromeo Hosp, Dept Cardiol, Milan, Italy
[5] San Gerardo Hosp, Monza, Italy
[6] San Leopoldo Mand, Merate, Lecco, Italy
来源：
EUROPEAN HEART JOURNAL | 2011年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：879 / 879
页数：1
相关论文
共 37 条
  • [11] Autologous bone-marrow stem cell mobilization induced by G-CSF after sub-acute ST segment elevation myocardial infarction undergoing late revascularisation
    Franz, W. M.
    Engelmann, M. G.
    Theiss, H. D.
    Hennig-Theiss, C.
    Huber, A.
    Wintersperger, B. J.
    Schoenberg, S. O.
    Steinbeck, G.
    EUROPEAN HEART JOURNAL, 2006, 27 : 279 - 280
  • [12] Effects of stem cell therapy with G-CSF on coronary artery after drug-eluting stent implantation in patients with acute myocardial infarction
    Kang, H-J
    Kim, Y-S
    Koo, B-K
    Park, K. W.
    Lee, H-Y
    Sohn, D-W
    Oh, B-H
    Park, Y-B
    Kim, H-S
    HEART, 2008, 94 (05) : 604 - 609
  • [13] Intracoronary infusion of the mobilized peripheral blood stem cell by G-CSF is better than mobilization alone by G-CSF for improvement of cardiac function and remodeling: 2-Year follow-up results of the Myocardial Regeneration and Angiogenesis in Myocardial Infarction with G-CSF and Intra-Coronary Stem Cell Infusion (MAGIC Cell) 1 trial
    Kang, Hyun-Jae
    Kim, Hyo-Soo
    Koo, Bon-Kwon
    Kim, Yong-Jin
    Lee, DongSoo
    Sohn, Dae-Won
    Oh, Byung-Hee
    Park, Young-Bae
    AMERICAN HEART JOURNAL, 2007, 153 (02) : 237.e1 - 237.e8
  • [14] Bone Marrow-derived mesenchymal cell mobilization by granulocyte-colony stimulating factor after acute myocardial infarction - Results from the stem cells in myocardial infarction (STEMMI) trial
    Ripa, Rasmus Sejersten
    Haack-Sorensen, Mandana
    Wang, Yongzhong
    Jorgensen, Erik
    Mortensen, Steen
    Bindslev, Lene
    Friis, Tina
    Kastrup, Jens
    CIRCULATION, 2007, 116 (11) : I24 - I30
  • [15] Bone-marrow stem cell mobilization induced by granulocyte-colony stimulating factor in patients undergoing delayed revascularisation for ST segment elevation myocardial infarction: Early results from the G-CSF in STEMI trial
    Engelmann, MG
    Theiss, HD
    Hennig, C
    Wintersperger, BJ
    Huber, A
    Schoenberg, SO
    Steinbeck, G
    Franz, WM
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (03) : 238A - 238A
  • [16] Effects of losartan and captopril on left ventricular systolic and diastolic function after acute myocardial infarction:: Results of the Optimal Trial in Myocardial Infarction with Angiotensin II Antagonist Losartan (OPTIMAAL) echocardiographic substudy
    Moller, JE
    Dahlström, U
    Gotzsche, O
    Lahiri, A
    Skagen, K
    Andersen, GS
    Egstrup, K
    AMERICAN HEART JOURNAL, 2004, 147 (03) : 494 - 501
  • [17] Regional myocardial systolic function measured with myocardial velocity imaging improves with the transplantation of autologous bone marrow-derived stem cells in patients with large acute myocardial infarction
    Herbots, L
    Eroglu, E
    Thijs, D
    Ganame, J
    Claus, P
    Dymarkowski, S
    Bogaert, J
    Herregods, MC
    Van de Werf, F
    Rademakers, F
    D'hooge, J
    Janssens, S
    CIRCULATION, 2005, 112 (17) : U643 - U643
  • [18] Influence of bone marrow stem cells on left ventricle perfusion and ejection fraction in patients with acute myocardial infarction of anterior wall: randomized clinical trial
    Grajek, Stefan
    Popiel, Malgorzata
    Gil, Lidia
    Breborowicz, Piotr
    Lesiak, Maciej
    Czepczynski, Rafal
    Sawinski, Krzysztof
    Straburzynska-Migaj, Ewa
    Araszkiewicz, Aleksander
    Czyz, Anna
    Kozlowska-Skrzypczak, Maria
    Komarnicki, Mieczyslaw
    EUROPEAN HEART JOURNAL, 2010, 31 (06) : 691 - 702
  • [19] Mobilization and elimination of FLT3-ITD+ acute myelogenous leukemia (AML) stem/progenitor cells by plerixafor, G-CSF, and sorafenib: Phase I trial results in relapsed/refractory AML patients.
    Andreeff, Michael
    Borthakur, Gautam
    Zeng, Zhihong
    Kelly, Mary A.
    Wang, Rui-Yu
    McQueen, Teresa J.
    Qiu, Yihua
    Mak, Duncan
    Burger, Jan Andreas
    Daver, Naval Guastad
    Pemmaraju, Naveen
    Kadia, Tapan M.
    Jabbour, Elias
    Pierce, Sherry
    Ravandi, Farhad
    Garcia-Manero, Guillermo
    O'Brien, Susan Mary
    Cortes, Jorge E.
    Kantarjian, Hagop M.
    Konopleva, Marina
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [20] Mobilization and Elimination of FLT3-ITD+ Acute Myelogenous Leukemia (AML) Stem/Progenitor Cells by Plerixafor/G-CSF/Sorafenib: Results From a Phase I Trial in Relapsed/Refractory AML Patients
    Andreeff, Michael
    Zeng, Zhihong
    Kelly, Mary A.
    Wang, Rui-yu
    McQueen, Teresa
    Duvvuri, Seshagiri
    Nowshad, Gul
    Borthakur, Gautam
    Burger, Jan A.
    Kadia, Tapan M.
    Jabbour, Elias
    Cortes, Jorge E.
    Kantarjian, Hagop M.
    Konopleva, Marina
    BLOOD, 2012, 120 (21)
1234